Alpaugh et al. showed that intraventricular infusion of GM1 ganglioside ameliorated motor defects, brain atrophy, neurodegeneration, and huntingtin levels in three different HD mouse models: R6/2, Q140, and YAC128 [44]. The gene discussed is HTT; the disease is Huntington disease.